Interestingly, in AD patients, donepezil alters astrocyte-induced neuroinflammatory responses by regulating kallikrein kinin signaling, a critical pathophysiological mediator of Aβ-induced neuroinflammation pathology [57]. The gene discussed is KLK4; the disease is Alzheimer disease.